The findings that reduced levels of MIAT enhanced both basal apoptosis of breast cancer cells and their response to a range of apoptotic stimuli could therefore have important clinical significance in relation to the response of breast tumors to cytotoxic therapy. This evidence concerns the gene MIAT and breast neoplasm.